Press Releases
- Johnson & Johnson Reports 2014 Second-Quarter Results
- Orphan Drug Approvals Have Increased, But High Costs Pose Challenges for Patients
- Titan Spine Receives FDA Clearance To Launch Endoskeleton® TL Device For Lateral Spinal Fusion
- La Jolla Pharmaceutical Announces Positive Pre-Clinical Data for Oral Galectin-3 Inhibitor in Nonalcoholic Steatohepatitis (NASH)
- BIAL and moksha8 announce exclusive license for the commercialization of eslicarbazepine acetate (Zebinix® / Exalief®) in Brazil and Mexico
- More Press Releases
Featured Jobs

